These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10166759)

  • 1. Supervisor ideology and organizational response: HIV/AIDS prevention in outpatient substance abuse treatment units.
    Clapp JD; Burke AC
    Adm Soc Work; 1997; 21(1):49-64. PubMed ID: 10166759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ownership differences in the provision of outpatient substance abuse services.
    Burke AC; Rafferty JA
    Adm Soc Work; 1994; 18(3):59-91. PubMed ID: 10138940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational factors related to AIDS/HIV education in outpatient substance abuse treatment units.
    Clapp JD
    J Health Soc Policy; 1998; 9(3):1-13. PubMed ID: 10174381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient substance abuse treatment and HIV prevention: an update.
    Pollack HA; D'Aunno T; Lamar B
    J Subst Abuse Treat; 2006 Jan; 30(1):39-47. PubMed ID: 16377451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units.
    D'Aunno T; Vaughn TE; McElroy P
    J Health Soc Behav; 1999 Jun; 40(2):175-92. PubMed ID: 10467763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statement on AIDS initiatives in drug treatment services in New York City. Committee on Public Health.
    Bull N Y Acad Med; 1991; 67(4):402-4. PubMed ID: 1651139
    [No Abstract]   [Full Text] [Related]  

  • 8. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005.
    Pollack HA; D'Aunno T
    J Subst Abuse Treat; 2010 Jun; 38(4):307-16. PubMed ID: 20171038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of drug abuse treatment for primary prevention of acquired immunodeficiency syndrome: epidemiologic considerations.
    Lampinen TM
    NIDA Res Monogr; 1991; 113():114-28. PubMed ID: 1762635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A community-based organization's integration of HIV and substance abuse treatment services for ex-offenders.
    Strauss D
    Soc Work Health Care; 2006; 42(3-4):61-76. PubMed ID: 16687375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.
    Rothman J; Rudnick D; Slifer M; Agins B; Heiner K; Birkhead G
    J Urban Health; 2007 Mar; 84(2):226-42. PubMed ID: 17216572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do drug treatment organizations use contingent staffing arrangements? An analysis of market and social influences.
    Lemak CH; Alexander JA; Roy J
    J Health Soc Behav; 2003 Jun; 44(2):180-97. PubMed ID: 12866389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
    Lima ES; Bastos FI; Telles PR; Friedman SR
    Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug abuse treatment as a strategy to prevent human immunodeficiency virus infection among intravenous drug users. How can we maximize prevention of infection?
    West AP
    Arch Intern Med; 1991 Aug; 151(8):1493-6. PubMed ID: 1651688
    [No Abstract]   [Full Text] [Related]  

  • 16. Health services research: drug use and human immunodeficiency virus in the United States.
    Flanzer J
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S439-44. PubMed ID: 14648461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating HIV prevention into substance user treatment: current practices and challenges.
    Mitchell CG; Oltean A
    Subst Use Misuse; 2007; 42(14):2173-82. PubMed ID: 18097998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHS grants for minority group HIV infection education and prevention efforts.
    Bowles J; Robinson WA
    Public Health Rep; 1989; 104(6):552-9. PubMed ID: 2511587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention epidemiologic research studies of HIV/AIDS. Centers for Disease Control and Prevention.
    Fed Regist; 1999 May; 64(97):27560-4. PubMed ID: 10558513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.